Chromatographic separations for mRNA therapeutics: developing platform process for a new therapeutic modality
Chromatographic separations for mRNA therapeutics: developing platform process for a new therapeutic modality
批准号:
2424139
负责人:
金额:
$0.0万
依托单位国家:
英国
项目类别:
Studentship
财政年份:
2020
资助国家:
英国
项目状态:
未结题
起止时间:
2020 至 --
中文摘要
最近mRNA产品作为主要的COVID-19候选疫苗的突出地位给其生产带来了巨大挑战。成功将推动mRNA的使用进入一系列新的治疗应用,并需要更好地理解制造过程。利用噬菌体RNA聚合酶对DNA进行体外转录(IVT)是目前制备长序列特异性RNA最有效的方法。与基于细胞的合成相比,IVT是一个相对简单的过程,它允许模板定向合成从短寡核苷酸到几千碱基的任何序列的RNA分子。IVT mRNA对体内合成编码治疗蛋白的重要性日益增加,这就要求制造纯mRNA产品。虽然该反应可以产生大量的RNA,但由于聚合酶的各种不需要的活性,它含有杂质。这些产物相关的杂质包括无帽mRNA、双链RNA和短单链RNA。它们通过阻碍mRNA的功效和最重要的激活免疫反应显著影响产品质量。该项目旨在通过首先了解IVT反应中产品相关杂质的性质来解决这一纯化挑战,其次在此基础上开发具有成本效益和可扩展的色谱分离,可以将这些杂质去除到适合临床应用的规格。
英文摘要
The recent prominence of mRNA products as leading COVID-19 vaccine candidates places huge challenges on their manufacture. Success would drive the use of mRNA into a whole range of new therapeutic applications and the need for well understood manufacturing processes.In vitro transcription (IVT) of DNA with phage RNA polymerases is currently the most efficient method to produce long sequence-specific RNA. IVT is a relatively simple procedure when compared to cell based synthesis that allows for template-directed synthesis of RNA molecules of any sequence from short oligonucleotides to those of several kilobases. The increasing importance of IVT mRNA for synthesising the encoded therapeutic protein in vivo demands the manufacturing of pure mRNA products. While the reaction can yield large quantities of RNA, it contains impurities due to various unwanted activities of the polymerases. These product-related impurities include uncapped mRNA, double-stranded RNA, and short single stranded RNA. They significantly impact product quality, both by hampering mRNA efficacy and of most concern activating immune responses.This project seeks to address this purification challenge by first understanding the nature of product related impurities in IVT reactions and secondly on the basis of this understanding developing cost effective and scalable chromatographic separations that can remove these impurities to a specification suitable for clinical applications.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金